Clinical Trial Update: Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia) [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing azilsartan medoxomil 80 mg tablets from Gedeon Richter with Edarbi 80 mg tablets for hypertension; the trial status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Azilsartan Medoxomil 80 mg tablets (test formulation) (azilsartan medoxomil)
• Edarbi 80 mg tablets (comparator) (azilsartan medoxomil)

Snippet

Sponsor: Gedeon Richter Plc. | Conditions: Hypertension | Phase 1 | Status: NOT_YET_RECRUITING